CAMX.ST
Price:
$599
Market Cap:
$35.23B
Camurus AB (publ), a pharmaceutical company, develops and commercializes medicines for severe and chronic conditions in Europe, Australia, the United States, Japan, and internationally. The company offers Buvidal, a buprenorphine injection for the treatment of opioid dependence; episil oral liquid, a medical device for the treatment of inflammatory and painful conditions in the oral cavity; and Brixadi to treat opioid use disorder Its products pipeline also includes CAM2038 for the treatment of chronic pain; CAM2029, which is in phase III clinical trials for the treatment of acromegaly and neuroendocrine tumors, as well as in phase II clinical trial to treat polycystic liver diseases; and CA...[Read more]
Industry
Biotechnology
IPO Date
2015-12-03
Stock Exchange
STO
Ticker
CAMX.ST
According to Camurus AB (publ)’s latest financial reports and current stock price. The company's current ROE is 10.44%. This represents a change of 306.81% compared to the average of 2.57% of the last 4 quarters.
The mean historical ROE of Camurus AB (publ) over the last ten years is -18.44%. The current 10.44% ROE has changed -156.60% with respect to the historical average. Over the past ten years (40 quarters), CAMX.ST's ROE was at its highest in in the December 2014 quarter at 60.64%. The ROE was at its lowest in in the December 2018 quarter at -34.54%.
Average
-18.44%
Median
-17.04%
Minimum
-93.01%
Maximum
39.16%
Discovering the peaks and valleys of Camurus AB (publ) ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 417.41%
Maximum Annual ROE = 39.16%
Minimum Annual Increase = -163.60%
Minimum Annual ROE = -93.01%
Year | ROE | Change |
---|---|---|
2023 | 28.90% | 417.41% |
2022 | 5.59% | -152.42% |
2021 | -10.65% | -46.02% |
2020 | -19.74% | -56.99% |
2019 | -45.89% | -50.66% |
2018 | -93.01% | 87.89% |
2017 | -49.50% | 244.95% |
2016 | -14.35% | -42.39% |
2015 | -24.91% | -163.60% |
2014 | 39.16% | -80.25% |
The current ROE of Camurus AB (publ) (CAMX.ST) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
7.94%
5-year avg
-8.36%
10-year avg
-18.44%
Camurus AB (publ)’s ROE is greater than BioArctic AB (publ) (-8.62%), greater than Calliditas Therapeutics AB (publ) (-210.18%), greater than Oncopeptides AB (publ) (-280.43%), less than Hansa Biopharma AB (publ) (242.32%), less than Swedish Orphan Biovitrum AB (publ) (9.82%),
Company | ROE | Market cap |
---|---|---|
-8.62% | $12.56B | |
-210.18% | $11.24B | |
-280.43% | $438.37M | |
242.32% | $2.19B | |
9.82% | $111.69B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Camurus AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Camurus AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Camurus AB (publ)'s ROE?
How is the ROE calculated for Camurus AB (publ) (CAMX.ST)?
What is the highest ROE for Camurus AB (publ) (CAMX.ST)?
What is the 3-year average ROE for Camurus AB (publ) (CAMX.ST)?
What is the 5-year average ROE for Camurus AB (publ) (CAMX.ST)?
How does the current ROE for Camurus AB (publ) (CAMX.ST) compare to its historical average?